TickerFactsScreenerDevelopers

Passage BIO, Inc. (PASG) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: -$39.90M2020: -$80.52M2021: -$126.88M2022: -$118.21M2023: -$78.26M2024: -$47.96M2025: -$31.51M-$31.51M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$31.51M+34.3%
2024-$47.96M+38.7%
2023-$78.26M+33.8%
2022-$118.21M+6.8%
2021-$126.88M-57.6%
2020-$80.52M-101.8%
2019-$39.90M—